← FDA DRUG APPROVALS

FDA ANDA · ANDA087537

ISOSORBIDE DINITRATE

Sponsor: PH HEALTH

APPLICATION
ANDA087537
TYPE
ANDA
ORIGINAL APPROVAL
1987-10-02
LATEST ACTION
2025-01-08
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

ISOSORBIDE DINITRATEPrescription
ISOSORBIDE DINITRATE 20MG · TABLET · ORAL

Approval history

2025-01-08Labeling · Supplement 24 · standardAP
2002-05-24Labeling · Supplement 20AP
1999-12-07Labeling · Supplement 19AP
1997-06-23Labeling · Supplement 18AP
1996-07-11Labeling · Supplement 17AP
1994-03-16Manufacturing (CMC) · Supplement 14AP
1994-03-16Manufacturing (CMC) · Supplement 15AP
1991-11-01Labeling · Supplement 16AP
1987-10-02OriginalAP
1984-12-04Manufacturing (CMC) · Supplement 8AP
1982-09-28Manufacturing (CMC) · Supplement 1AP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →